These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30141237)

  • 1. Exact and asymptotic tests under the sequential parallel comparison design.
    Lui KJ
    Pharm Stat; 2018 Nov; 17(6):835-845. PubMed ID: 30141237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptotic and exact interval estimators of the common odds ratio under the sequential parallel comparison design.
    Lui KJ
    Stat Methods Med Res; 2019; 28(10-11):3074-3085. PubMed ID: 30156122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the relative difference (or relative risk reduction) under the sequential parallel comparison design.
    Lui KJ
    Stat Methods Med Res; 2019 Jul; 28(7):2125-2136. PubMed ID: 29284368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exact tests in binary data under an incomplete block crossover design.
    Lui KJ; Chang KC
    Stat Methods Med Res; 2018 Feb; 27(2):579-592. PubMed ID: 27005298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Poisson frequency data under a simple crossover trial.
    Lui KJ; Chang KC
    Stat Methods Med Res; 2016 Feb; 25(1):385-99. PubMed ID: 22899697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of adaptive design variations on the sequential parallel comparison design for clinical trials.
    Mi MY; Betensky RA
    Clin Trials; 2013 Apr; 10(2):207-15. PubMed ID: 23283576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size determination for testing equality in Poisson frequency data under an AB/BA crossover trial.
    Lui KJ
    Pharm Stat; 2013; 12(2):74-81. PubMed ID: 23364859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
    Mischoulon D; Witte J; Levy M; Papakostas GI; Pet LR; Hsieh WH; Pencina MJ; Ward S; Pollack MH; Fava M
    J Clin Psychiatry; 2012 Mar; 73(3):353-7. PubMed ID: 21939613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
    Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
    Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review.
    Salloum NC; Fava M; Ball S; Papakostas GI
    Mol Psychiatry; 2020 Sep; 25(9):1967-1974. PubMed ID: 31988433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample Size Determination for a 3-Treatment 3-Period Crossover Trial in Frequency Data.
    Lui KJ
    Ther Innov Regul Sci; 2018 Jul; 52(4):407-415. PubMed ID: 29714548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-free tests of equality in binary data under an incomplete block design.
    Lui KJ; Zhu L
    J Biopharm Stat; 2018; 28(6):1160-1168. PubMed ID: 29452049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy.
    Nelson JC; Thase ME; Bellocchio EE; Rollin LM; Eudicone JM; McQuade RD; Marcus RN; Berman RM; Baker RA
    Int Clin Psychopharmacol; 2012 May; 27(3):125-33. PubMed ID: 22466058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomes.
    Homma G; Daimon T
    Pharm Stat; 2019 Mar; 18(2):184-197. PubMed ID: 30411482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.
    Weisler RH; Khan A; Trivedi MH; Yang H; Eudicone JM; Pikalov A; Tran QV; Berman RM; Carlson BX
    J Clin Psychiatry; 2011 Apr; 72(4):548-55. PubMed ID: 20816039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies.
    Doros G; Pencina M; Rybin D; Meisner A; Fava M
    Stat Med; 2013 Jul; 32(16):2767-89. PubMed ID: 23355369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimality, sample size, and power calculations for the sequential parallel comparison design.
    Ivanova A; Qaqish B; Schoenfeld DA
    Stat Med; 2011 Oct; 30(23):2793-803. PubMed ID: 21805484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test Equality between Three Treatments under an Incomplete Block Crossover Design.
    Lui KJ
    J Biopharm Stat; 2015; 25(4):795-811. PubMed ID: 24905582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy.
    Casey DE; Laubmeier KK; Eudicone JM; Marcus R; Berman RM; Rahman Z; Sheehan J
    Int J Clin Pract; 2014 Nov; 68(11):1301-8. PubMed ID: 25196314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.